Analyst Ratings for BioMarin Pharmaceutical Inc. (BMRN)
BMRN Rating Summary
BMRN Price Target Summary
- Highest: $120.00 (TD Cowen)
- Lowest: $55.00 (H.C. Wainwright)
- Average: $91.27
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$91.27 (+49.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays » Updated 3/3/2026 |
Eliana Merle | New Coverage | Overweight (N/A) |
105.00 (80.00) |
56.78 (61.12) |
7.64% | Details |
| 1/20/2026 | Canaccord » Updated 2/26/2026 |
Whitney Ijem | Upgrade | Buy (Hold) |
104.00 (98.00) |
55.07 (61.12) |
10.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
